CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −22 | $8.55 | $188 | 4,355 |
| 2026-06-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −52 | $6.71 | $349 | 4,377 |
| 2026-03-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −60 | $6.84 | $410 | 4,429 |
| 2026-02-03 | DeLucia David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-12-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −52 | $8.42 | $438 | 4,489 |
| 2025-09-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −53 | $12.10 | $641 | 4,541 |
| 2025-06-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −51 | $7.83 | $399 | 4,594 |
| 2025-03-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −2,325 | $0.39 | $907 | 116,137 |
| 2025-01-09 | DeLucia David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 |
Page 1 of 1 · 9 trades